South San Francisco, CA, United States of America

Cortexyme, Inc.


USPTO Granted Patents = 9

% Expired Patents = 22.2


Trademarks = 2

Forward Citations = 26

Loading Chart...
Loading Chart...

7 inventors (with patents filed for the assignee):

goldMedal Casey Crawford Lynch (9 out of 10 patents)

silverMedal Andrei William Konradi (9 out of 88 patents)

bronzeMedal Stephen S Dominy (8 out of 9 patents)

4.  Craig Alan Coburn (6 out of 58 patents)

5.  Joseph P Vacca (6 out of 110 patents)

6.  Robert A Galemmo, Jr (3 out of 4 patents)

7.  Leslie Jean Holsinger (2 out of 4 patents)


9 patents:

Cortexyme, Inc. is a biopharmaceutical company focused on developing therapeutics for Alzheimer's disease and other degenerative disorders. The company's lead candidate, COR388, targets a specific bacterial infection associated with the development of Alzheimer's disease. Cortexyme is pioneering the field of pathogen-targeted therapeutics, with the goal of addressing the root cause of neurodegenerative disorders.
Profile summary based on public USPTO records.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

9 Patents

#110 in South San Francisco, CA

#7,730 in California

#32,565 in US

South San Francisco, CA (US)
South San Francisco, CA, United States of America
Forward Citations = 26

7 inventors:

Please report any incorrect information to [email protected]
Loading…